Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

Temsirolimus is an inhibitor of the mammalian target of rapamycin (mTOR) kinase, a protein that has been shown to be particularly active in metastatic renal cell carcinoma (mRCC) with poor prognosis. Therefore, temsirolimus should be considered as the first-line treatment indicated in mRCC patients...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Urol
Main Authors: Zanardi, Elisa, Verzoni, Elena, Grassi, Paolo, Necchi, Andrea, Giannatempo, Patrizia, Raggi, Daniele, De Braud, Filippo, Procopio, Giuseppe
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2015
Fag:
Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485412/
https://ncbi.nlm.nih.gov/pubmed/26161146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215574457
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker